Daniel R. Wieland

Daniel R. Wieland

Auto-generated profile, based on publicly available information

Daniel R. Wieland

Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ALAbby L’hEureux
Abby L’hEureux
DWDaniel R. Wieland
Daniel R. Wieland
YCYi-Huei Chen
Yi-Huei Chen
CLChing-Heng Lin
Ching-Heng Lin
TLTseng-Hsi Lin
Tseng-Hsi Lin
CWChien-Hsiang Weng
Chien-Hsiang Weng
Colorectal cancer (CRC) is an increasingly common disease with far-reaching consequences.1 It is the third most common cancer worldwide2 and the third leading cause of cancer-associated deaths in the United States, in which 1 in 22 men and 1 in 24 women are expected to develop the disease over the course of their lifetimes.3 Great efforts have been made to further characterize and understand the pathogenesis of CRC to develop new, more effective treatments for the disease.4-6 As is the case with many neoplastic processes, with CRC genetic and molecular alterations appear to be involved, leading to uncontrolled proliferation of these abnormal cells.4

9 September 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
VTValery F. Thompson
Valery F. Thompson
DWDaniel R. Wieland
Daniel R. Wieland
VMVivian Mendoza-Leon
Vivian Mendoza-Leon
HJHelen I. Janis
Helen I. Janis
MLMichelle A. Lay
Michelle A. Lay
JSJacob C. Schwartz
Jacob C. Schwartz
The protein FUS (FUSed in sarcoma) is a metazoan RNA-binding protein that influences RNA production by all three nuclear polymerases. FUS also binds nascent transcripts, RNA processing factors, RNA polymerases, and transcription machinery. Here, we explored the role of FUS binding interactions for activity during transcription. In vitro run-off transcription assays revealed FUS-enhanced RNA produced by a non-eukaryote polymerase. The activity also reduced the formation of R-loops between RNA products and their DNA template. Analysis by domain mutation and deletion indicated RNA-binding was required for activity. We interpret that FUS binds and sequesters nascent transcripts to prevent R-loops from forming with nearby DNA. DRIP-seq analysis showed that a knockdown of FUS increased R-loop enrichment near expressed genes. Prevention of R-loops by FUS binding to nascent transcripts has the potential to affect transcription by any RNA polymerase, highlighting the broad impact FUS can have on RNA metabolism in cells and disease.

19 September 2020 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CWChien-Hsiang Weng
Chien-Hsiang Weng
DWDaniel R. Wieland
Daniel R. Wieland
XLXun Luo
Xun Luo
KWKatherine L. Webb
Katherine L. Webb
GPGeorge D. Papandonatos
George D. Papandonatos